News - Sanofi Pasteur, Antibiotics and Infectious diseases


Popular Filters

Sanofi Pasteur and Vivalis extend MAb accord


French biopharma company Vivalis (NYSE Euronext: VLS) says it has extended the agreement signed in 2010…

Antibiotics and Infectious diseasesLicensingPharmaceuticalResearchSanofiSanofi PasteurVivalis

Sanofi Pasteur and CureVac collaborate on a $33.1 million project on vaccines for infectious diseases


Germany’s CureVac says it has signed several agreements with Sanofi Pasteur, the vaccines division…

Antibiotics and Infectious diseasesBiotechnologyCureVacLicensingPharmaceuticalResearchSanofiSanofi PasteurVaccines

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top